abstract |
This invention provides novel arylindenopyrimidines of the Formula (I), n n n n n n n n n n and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing adenosine A1 and/or A2a receptors. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions. |